CHICAGO  (July 25, 2013) – Ulmer & Berne LLP is pleased to announce the addition of Patrick G. King as a partner in the firm’s Financial Services and Securities Litigation practice group. Based in the firm’s Chicago office, Mr. King joins Ulmer & Berne from Neal, Gerber & Eisenberg LLP, where he was a partner.

“With two decades of experience in securities and commodities litigation arbitration, Pat is a well-known and highly regarded attorney who adds even more depth and talent to our practice,” said Michael N. Ungar, chair of Ulmer & Berne’s Litigation Department. “His arrival is consistent with the rapid growth of our already robust securities and financial litigation practice.”

Mr. King advises financial services clients regarding litigation, arbitration, employment disputes, enforcement proceedings, and internal investigations, with a focus in the areas of futures, derivatives, securities, and commodities. He also counsels clients regarding compliance with federal and state securities and commodities regulations in connection with public and private securities offerings. Mr. King has represented many of the largest financial institutions in litigation, arbitration, regulatory and other matters throughout the country.

“We welcome Pat to the Chicago office,” said Michael D. Switzer, partner-in-charge of the firm’s Chicago office. “He is a great fit and key addition to our growth strategy, which has been in high gear these past couple of years.”

Mr. King earned his J.D. from John Marshall Law School and his B.A. from Benedictine University.

About Ulmer & Berne LLP

Ulmer & Berne, established in 1908, is a full-service law firm focused on exceeding client expectations and delivering superior, customized legal solutions for an exceptional value. Its more than 185 attorneys, located in Chicago, Cincinnati, Cleveland and Columbus, serve as counselors and partners to a wide range of clients to help them solve their business challenges and achieve their goals. The firm represents publicly traded and privately held companies, financial institutions, hedge funds, private equity funds, pharmaceutical companies, international joint ventures and affiliations, investor groups, family offices, start-ups and emerging businesses, public bodies and nonprofit organizations. For more information, please visit